P2B-080

Hemato Oncology Clinic, Vedanta Institute of Medical Science (Ahmedabad, India) › P2B-080

P2B-080

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Hemato Oncology Clinic, Vedanta Institute of Medical Science (Ahmedabad, India) · Dr. Ito
consented 2013-02-24

screened

AEs

0

Serious

0

Dropout signal

–

Adverse events

0

No adverse events recorded. New events are triaged from the Safety tab.

Data queries

0

No data queries. Open queries would appear here for this patient.